{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:55:06Z","timestamp":1792223706981,"version":"4.4.0"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00941","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T04:04:37Z","timestamp":1557461077000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":111,"title":["Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form"],"prefix":"10.3389","volume":"10","author":[{"given":"Tamara","family":"Kolitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shachaf","family":"Shiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzhak","family":"Sharabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asher","family":"Winder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele","family":"Zandman-Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/ard.2005.045443","article-title":"Infectious origin of the antiphospholipid syndrome*","volume":"65","author":"Shoenfeld","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11926-010-0149-3","article-title":"Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: Where do we stand?","volume":"13","author":"Barbhaiya","year":"2011","journal-title":"Curr Rheumatol Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1365-2796.2011.02362.x","article-title":"Antiphospholipid syndrome: Laboratory detection, mechanisms of action and treatment","volume":"270","author":"Tripodi","year":"2011","journal-title":"JIM."},{"key":"B5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.autrev.2005.06.005","article-title":"Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases","volume":"5","author":"Jara","year":"2006","journal-title":"Autoimmun Rev."},{"key":"B6","first-page":"162","article-title":"Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of serbian patients with primary and secondary antiphospholipid syndrome","volume":"16","author":"Djokovic","year":"2014","journal-title":"IMAJ."},{"key":"B7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jaut.2016.10.004","article-title":"The antiphospholipid syndrome in patients with systemic lupus erythematosus","volume":"76","author":"Pons-Estel","year":"2017","journal-title":"J Autoimmun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10067-014-2486-5","article-title":"The spectrum between antiphospholipid syndrome and systemic lupus erythematosus","volume":"33","author":"Agmon-Levin","year":"2014","journal-title":"J Clin Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1002\/art.21224","article-title":"Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups","volume":"52","author":"Mok","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/BOR.0b013e32832effdd","article-title":"Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?","volume":"21","author":"Shoenfeld","year":"2009","journal-title":"Curr Opin Rheumatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.berh.2012.01.006","article-title":"Much more than thrombosis and pregnancy loss: The antiphospholipid syndrome as a \u201csystemic disease","volume":"26","author":"Taraborelli","year":"2012","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.autrev.2018.03.011","article-title":"Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: analysis of a cohort of 214 patients","volume":"17","author":"Paule","year":"2018","journal-title":"Autoimmun Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/0002-8703(92)90420-Z","article-title":"Cardiac manifestations of the antiphospholipid syndrome","volume":"124","author":"Kaplan","year":"1992","journal-title":"Am Heart J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/0961203310395051","article-title":"Task force on catastrophic antiphospholipid syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions","volume":"20","author":"Cervera","year":"2011","journal-title":"Lupus."},{"key":"B16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.rdc.2006.05.008","article-title":"Cardiac manifestations in the antiphospholipid syndrome","volume":"32","author":"Tenedios","year":"2006","journal-title":"Rheum Dis Clin North Am."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.echo.2009.06.023","article-title":"The cardiac manifestations of antiphospholipid syndrome and their echocardiographic recognition","volume":"22","author":"Silbiger","year":"2009","journal-title":"J Am Soc Echocardiogr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1136\/hrt.2007.132787","article-title":"Valvular and coronary heart disease in systemic inflammatory diseases: systemic disorders in heart disease","volume":"94","author":"Roldan","year":"2008","journal-title":"Heart."},{"key":"B19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.hoc.2007.10.002","article-title":"The role of antiphospholipid syndrome in cardiovascular disease","volume":"22","author":"Long","year":"2008","journal-title":"Hematol Oncol Clin North Am."},{"key":"B20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0049-0172(97)80034-0","article-title":"Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment","volume":"27","author":"Nesher","year":"1997","journal-title":"Semin Arthritis Rheum."},{"key":"B21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-116-4-293","article-title":"Valvular heart disease in the primary antiphospholipid syndrome","volume":"116","author":"Galve","year":"1992","journal-title":"Ann Intern Med."},{"key":"B22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0735-1097(91)90749-Y","article-title":"Cardiac involvement in patients with primary antiphospholipid syndrome","volume":"18","author":"Brenner","year":"1991","journal-title":"J Am Coll Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/01.CIR.93.8.1579","article-title":"Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome","volume":"93","author":"Hojnik","year":"1996","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.111.028522","article-title":"Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies","volume":"124","author":"Zuily","year":"2011","journal-title":"Circulation."},{"key":"B25","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1161\/01.STR.0000154858.27353.df","article-title":"Assessment of cardiac structure and left atrial appendage functions in primary antiphospholipid syndrome: a transesophageal echocardiographic study","volume":"36","author":"Erdogan","year":"2005","journal-title":"Stroke."},{"key":"B26","doi-asserted-by":"publisher","first-page":"P12","DOI":"10.1186\/ar1535","article-title":"Close association between valvular heart disease and central nervous system manifestations in antiphospholipid syndrome","volume":"7","author":"Krause","year":"2005","journal-title":"Ann Rheum Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/0961203309353772","article-title":"Echocardiography at diagnosis of antiphospholipid syndrome provides prognostic information on valvular disease evolution and identifies two subtypes of patients","volume":"19","author":"Pardos-Gea","year":"2010","journal-title":"Lupus."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.amjcard.2005.02.010","article-title":"Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus","volume":"95","author":"Roldan","year":"2005","journal-title":"Am J Cardiol."},{"key":"B29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/096120339600500111","article-title":"Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings","volume":"5","author":"Garc\u00eda-Torres","year":"1996","journal-title":"Lupus."},{"key":"B30","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.amjcard.2005.04.022","article-title":"Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome","volume":"96","author":"Turiel","year":"2005","journal-title":"Am J Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1006\/jaut.2000.0405","article-title":"Recent advances in antiphospholipid antibody-related valvulopathies","volume":"15","author":"Cervera","year":"2000","journal-title":"J Autoimmun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/096120339600500306","article-title":"Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves","volume":"5","author":"Ziporen","year":"1996","journal-title":"Lupus."},{"key":"B33","first-page":"99","article-title":"Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease","volume":"17","author":"Amital","year":"1999","journal-title":"Clin Exp Rheumatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/rheumatology\/kel118","article-title":"Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome","volume":"45","author":"Blank","year":"2006","journal-title":"Rheumatology."},{"key":"B35","first-page":"1175","article-title":"Anticardiolipin antibodies in acute rheumatic fever","volume":"19","author":"Figueroa","year":"1992","journal-title":"J Rheumatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1161\/CIRCULATIONAHA.104.507996","article-title":"Accelerated atherosclerosis in autoimmune rheumatic diseases","volume":"112","author":"Shoenfeld","year":"2005","journal-title":"Circulation."},{"key":"B37","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.semarthrit.2017.10.015","article-title":"Carotid and femoral atherosclerosis in antiphospholipid syndrome: equivalent risk with diabetes mellitus in a case-control study","volume":"47","author":"Kravvarti","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"New Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/ard.62.7.607","article-title":"Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome","volume":"62","author":"Medina","year":"2003","journal-title":"Ann Rheum Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/107602960200800205","article-title":"Are antiphospholipid antibodies an independent risk factor for atherosclerosis?","volume":"8","author":"Bilora","year":"2002","journal-title":"Clin Appl Thromb Hemost."},{"key":"B41","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1177\/0961203315617841","article-title":"Primary antiphospholipid syndrome: absence of premature atherosclerosis in patients without traditional coronary artery disease risk factors","volume":"25","author":"Andrade","year":"2015","journal-title":"Lupus."},{"key":"B42","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1191\/0961203302lu165oa","article-title":"Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies","volume":"11","author":"Ames","year":"2002","journal-title":"Lupus."},{"key":"B43","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1191\/0961203303lu339oa","article-title":"Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients","volume":"12","author":"Solt\u00e9sz","year":"2003","journal-title":"Lupus."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1093\/rheumatology\/ken349","article-title":"Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction","volume":"47","author":"Soltesz","year":"2008","journal-title":"Rheumatology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.autrev.2012.03.002","article-title":"Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity","volume":"11","author":"Artenjak","year":"2012","journal-title":"Autoimmun Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/rheumatology\/keg182","article-title":"Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study","volume":"42","author":"Vlachoyiannopoulos","year":"2003","journal-title":"Rheumatology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.autrev.2013.03.013","article-title":"Cardiovascular disease in autoimmune rheumatic diseases","volume":"12","author":"Hollan","year":"2013","journal-title":"Autoimmun Rev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/10446670410001722186","article-title":"Are oxidized LDL\/\u03b22-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis?","volume":"11","author":"Matsuura","year":"2004","journal-title":"Clin Dev Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1191\/0961203305lu2211oa","article-title":"Oxidized LDL\/beta2-glycoprotein I complexes: new aspects in atherosclerosis","volume":"14","author":"Matsuura","year":"2005","journal-title":"Lupus."},{"key":"B50","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.autrev.2008.04.018","article-title":"Oxidation of LDL and its clinical implication","volume":"7","author":"Matsuura","year":"2008","journal-title":"Autoimmun Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.autrev.2005.08.008","article-title":"Premature atherosclerotic disease in systemic lupus erythematosus - role of inflammatory mechanisms","volume":"5","author":"Rhew","year":"2006","journal-title":"Autoimmun Rev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1194\/jlr.M200329-JLR200","article-title":"Circulating oxidized LDL forms complexes with \u03b2 2 -glycoprotein I","volume":"44","author":"Kobayashi","year":"2003","journal-title":"J Lipid Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/0140-6736(93)91213-6","article-title":"Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus","volume":"341","author":"Vaarala","year":"1993","journal-title":"Lancet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/rheumatology\/keg248","article-title":"Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"42","author":"Delgado","year":"2003","journal-title":"Rheumatology."},{"key":"B55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/1-84628-009-5_5","article-title":"Cardiac manifestations in antiphospholipid syndrome","author":"Font","year":"2006","journal-title":"Hughes Syndrome."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum."},{"key":"B57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1136\/pmj.78.915.27","article-title":"Acute myocardial infarction in young adults: causes and management","volume":"78","author":"Osula","year":"2002","journal-title":"Postgrad Med J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"129","DOI":"10.14740\/cr661w","article-title":"Coronary artery thromboses, stent thrombosis and antiphospholipid antibody syndrome: case report","volume":"9","author":"Correia","year":"2018","journal-title":"Cardiol Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12016-011-8268-9","article-title":"Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome","volume":"44","author":"Gualtierotti","year":"2013","journal-title":"Clin Rev Allergy Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/MCA.0000000000000476","article-title":"Acute myocardial infarction and antiphospholipid antibody syndrome: a systematic review","volume":"28","author":"Nazir","year":"2017","journal-title":"Coron Artery Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.autrev.2014.11.003","article-title":"Antiphospholipid syndrome and the heart: a case series and literature review","volume":"14","author":"Denas","year":"2015","journal-title":"Autoimmun Rev."},{"key":"B62","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1055\/s-2007-985755","article-title":"Arterial thrombosis and the role of thrombophilia","volume":"33","author":"Boekholdt","year":"2007","journal-title":"Semin Thromb Hemostl."},{"key":"B63","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1161\/01.CIR.82.2.369","article-title":"Cardiac abnormalities in systemic lupus erythematosus: association with raised anticardiolipin antibodies","volume":"82","author":"Nihoyannopoulos","year":"1990","journal-title":"Circulation."},{"key":"B64","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/096120339500400413","article-title":"The presence of antiphospholipid antibodies in acute myocardial infarction","volume":"4","author":"Adler","year":"1995","journal-title":"Lupus."},{"key":"B65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1161\/01.CIR.91.1.23","article-title":"Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men","volume":"91","author":"Vaarala","year":"1995","journal-title":"Circulation."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1111\/j.1538-7836.2007.02763.x","article-title":"Anti-beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women","volume":"5","author":"Meroni","year":"2007","journal-title":"J Thromb Haemost."},{"key":"B67","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1161\/01.STR.32.8.1701","article-title":"beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the Honolulu heart program","volume":"32","author":"Brey","year":"2001","journal-title":"Stroke."},{"key":"B68","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1191\/0961203304lu1011oa","article-title":"Antiphospholipid antibodies in acute coronary syndrome","volume":"13","author":"Veres","year":"2004","journal-title":"Lupus."},{"key":"B69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0140-6736(86)92258-0","article-title":"Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events","volume":"1","author":"Hamsten","year":"1986","journal-title":"Lancet."},{"key":"B70","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S1474-4422(09)70239-X","article-title":"Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study","volume":"8","author":"Urbanus","year":"2009","journal-title":"Lancet Neurol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1191\/096120301666383277","article-title":"Myocardial microangiopathy associated with antiphospholipid antibodies","volume":"10","author":"Lauwerys","year":"2001","journal-title":"Lupus."},{"key":"B72","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/heart.84.2.156","article-title":"Images in cardiology","volume":"84","author":"Azeem","year":"2000","journal-title":"Heart."},{"key":"B73","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1136\/ard.2005.044073","article-title":"Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome","volume":"66","author":"Paran","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.rdc.2005.01.011","article-title":"Antiphospholipid syndrome in systemic lupus erythematosus: is the whole greater than the sum of its parts?","volume":"31","author":"Laskin","year":"2005","journal-title":"Rheum Dis Clin North Am."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/0002-8703(95)90124-8","article-title":"Diastolic dysfunction is a feature of the antiphospholipid syndrome","volume":"129","author":"Hasnie","year":"1995","journal-title":"Am Heart J."},{"key":"B76","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.semarthrit.2013.07.016","article-title":"Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and\/or antiphospholipid syndrome: A 10-year follow-up study","volume":"43","author":"Kampolis","year":"2014","journal-title":"Semin Arthritis Rheum."},{"key":"B77","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/ard.60.1.43","article-title":"Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome","volume":"60","author":"Tektonidou","year":"2001","journal-title":"Ann Rheum Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1136\/bmj.296.6635.1505","article-title":"Fatal cardiac failure due to myocardial microthrombi in systemic lupus erythematosus","volume":"296","author":"Brown","year":"1988","journal-title":"BMJ."},{"key":"B79","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/hrt.62.1.61","article-title":"Findings at necropsy in the heart of a patient with anticardiolipin syndrome","volume":"62","author":"Murphy","year":"1989","journal-title":"Br Heart J."},{"key":"B80","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/039463200802100128","article-title":"Dilated cardiomyopathy due to thrombotic microangiopathy as the only manifestation of antiphospholipid syndrome: a case report","volume":"21","author":"Vaccaro","year":"2008","journal-title":"Int J Immunopathol Pharmacol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1056\/NEJMp048088","article-title":"Chronic thromboembolic pulmonary hypertension \u2014 not so rare after all","volume":"350","author":"Lang","year":"2004","journal-title":"NEJM."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s10067-011-1826-y","article-title":"Severe systemic lupus erythematosus in emergency department: a retrospective single-center study from China","volume":"30","author":"Chen","year":"2011","journal-title":"J Clin Rheumatol."},{"key":"B83","first-page":"942","article-title":"Pulmonary hypertension secondary to thrombosis of the pulmonary vessels in a patient with the primary antiphospholipid syndrome","volume":"21","author":"Brucato","year":"1994","journal-title":"J Rheumatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1183\/09031936.96.09020356","article-title":"The role of thrombosis in severe pulmonary hypertension","volume":"9","author":"Chaouat","year":"1996","journal-title":"ERJ."},{"key":"B85","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/1529-0131(199805)41:5<800::AID-ART5>3.0.CO;2-J","article-title":"Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1","volume":"41","author":"Atsumi","year":"1998","journal-title":"Arthritis Rheum."},{"key":"B86","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0002-9343(94)90108","article-title":"Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients","volume":"96","author":"Vianna","year":"1994","journal-title":"Am J Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/1756-185X.12191.","article-title":"Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long-time echocardiography follow-up study","volume":"1","author":"Pardos-Gea","year":"2015","journal-title":"Int J Rheum Dis."},{"key":"B88","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/01.CIR.84.2.920","article-title":"Antiphospholipid antibodies and the heart","volume":"84","author":"Asherson","year":"1991","journal-title":"Circulation."},{"key":"B89","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0002-8703(99)70424-2","article-title":"Echocardiographic evaluation of patients with primary antiphospholipid syndrome","volume":"137","author":"Esp\u00ednola-Zavaleta","year":"1999","journal-title":"Am Heart J."},{"key":"B90","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s11926-014-0478-8","article-title":"Pulmonary hypertension in antiphospholipid syndrome","volume":"17","author":"Zuily","year":"2015","journal-title":"Curr Rheumatol Rep."},{"key":"B91","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00001721-200109000-00002","article-title":"Thrombophilic factors in chronic thromboembolic pulmonary hypertension","volume":"12","author":"Colorio","year":"2001","journal-title":"Blood Coagul Fibrinoly."},{"key":"B92","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1034\/j.1399-3003.2000.15b28.x","article-title":"Thrombotic risk factors in pulmonary hypertension","volume":"15","author":"Wolf","year":"2000","journal-title":"ERJ."},{"key":"B93","first-page":"1313","article-title":"Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension","volume":"25","author":"Martinuzzo","year":"1998","journal-title":"J Rheumatol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/ehjci\/jer314","article-title":"Disseminated intracardiac thrombosis: a rare manifestation of antiphospholipid syndrome","volume":"13","author":"Abanador-Kamper","year":"2012","journal-title":"Eur Heart J Cardiovasc Imag."},{"key":"B95","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.acvd.2011.05.014","article-title":"Coronary microvasculopathy and intracardiac thrombosis in antiphospholipid syndrome","volume":"105","author":"Onea","year":"2012","journal-title":"Arch Cardiovasc Dis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.semarthrit.2015.09.005","article-title":"Cardiac involvement in antiphospholipid syndrome: the diagnostic role of noninvasive cardiac imaging","volume":"45","author":"Mavrogeni","year":"2016","journal-title":"Semin Arthritis Rheum."},{"key":"B97","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1191\/0961203303lu391oa","article-title":"Cardiac disease in the antiphospholipid syndrome: recommendations for treatment","author":"Lockshin","year":"2003","journal-title":"Lupus."},{"key":"B98","first-page":"2402","article-title":"Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic follow up study","volume":"31","author":"Zavaleta","year":"2004","journal-title":"J Rheumatol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.berh.2007.10.003","article-title":"The treatment of antiphospholipid syndrome: A harmonic contrast","volume":"21","author":"Ruiz-Irastorza","year":"2007","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"omy024","DOI":"10.1093\/omcr\/omy024","article-title":"Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome","volume":"6","author":"Sirinvaravong","year":"2018","journal-title":"Oxf Med Case Rep."},{"key":"B101","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s11926-013-0320-8","article-title":"Valvular heart disease in antiphospholipid syndrome","volume":"15","author":"Zuily","year":"2013","journal-title":"Curr Rheumatol Rep."},{"key":"B102","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/rheumatology\/kel308","article-title":"Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus","volume":"45","author":"Tincani","year":"2006","journal-title":"Rheumatology."},{"key":"B103","first-page":"2329","article-title":"Classification criteria for antiphospholipid syndrome: the case for cardiac valvular disease","volume":"31","author":"Petri","year":"2004","journal-title":"J Rheumatol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejcts.2007.11.004","article-title":"The antiphospholipid syndrome and heart valve surgery","volume":"33","author":"Gorki","year":"2008","journal-title":"Eur J Cardiothorac Surg."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/acr.21670","article-title":"Cardiac valve replacement in patients with antiphospholipid syndrome","volume":"14","author":"Erdozain","year":"2012","journal-title":"Arthritis Care Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jtcvs.2003.07.016","article-title":"Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery","volume":"127","author":"Berkun","year":"2004","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B107","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejcts.2009.06.046","article-title":"Heart valve surgery in patients with the antiphospholipid syndrome: analysis of a series of nine cases","volume":"37","author":"Colli","year":"2010","journal-title":"Eur J Cardiothorac Surg."},{"key":"B108","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.hlc.2007.03.010","article-title":"Cardiovascular surgical outcomes in patients with the antiphospholipid syndrome-a case-series","volume":"16","author":"Hegde","year":"2007","journal-title":"Heart Lung Circ."},{"key":"B109","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","article-title":"Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)","volume":"30","author":"Habib","year":"2009","journal-title":"Eur Heart J."},{"key":"B110","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2009","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1191\/0961203303lu2135oa","article-title":"Statins: immunomodulators for autoimmune rheumatic disease?","volume":"14","author":"Jury","year":"2005","journal-title":"Lupus."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"14","author":"Giannakopoulos","year":"2013","journal-title":"NEJM."},{"key":"B113","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s12026-013-8409-8","article-title":"Statins and autoimmunity","volume":"56","author":"Khattri","year":"2013","journal-title":"Immunol Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jaut.2009.05.002","article-title":"Management of antiphospholipid syndrome","volume":"33","author":"Tuthill","year":"2009","journal-title":"J Autoimmun."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1056\/NEJMoa035241","article-title":"A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome","volume":"349","author":"Crowther","year":"2003","journal-title":"NEJM."},{"key":"B116","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/j.1538-7836.2005.01340.x","article-title":"A randomized clinical trial of high-intensity warfarin vs","volume":"3","author":"Finazzi","year":"2005","journal-title":"J Thromb Haemost."},{"key":"B117","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/bjh.14632","article-title":"Pathogenesis and management of antiphospholipid syndrome","volume":"178","author":"Arachchillage","year":"2017","journal-title":"Br J Haematol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/HRT.79.1.96","article-title":"Primary antiphospholipid syndrome with acute myocardial infarction recanalised by PTCA","volume":"79","author":"Takeuchi","year":"1998","journal-title":"Heart."},{"key":"B119","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000338347","article-title":"Long-term outcome of patients with antiphospholipid syndrome who undergo percutaneous coronary intervention","volume":"122","author":"Perl","year":"2012","journal-title":"Cardiology."},{"key":"B120","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000177119","article-title":"Successful treatment of acute myocardial infarction by thrombolytic therapy in a patient with primary antiphospholipid antibody syndrome","volume":"87","author":"Ho","year":"1996","journal-title":"Cardiology."},{"key":"B121","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/BF02229652","article-title":"Immunosuppressive treatment in a heart transplantation candidate with antiphospholipid syndrome","volume":"15","author":"Pengo","year":"1996","journal-title":"J Clin Rheumatol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5582\/irdr.2017.01044","article-title":"Pulmonary hypertension associated with antiphospholipid antibody: Call for a screening tool?","volume":"6","author":"Parthvi","year":"2017","journal-title":"Intractable Rare Dis Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"NEJM."},{"key":"B124","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/annrheumdis-2018-213846","article-title":"Management of antiphospholipid syndrome","volume":"78","author":"Uthman","year":"2019","journal-title":"Ann Rheum Dis."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00941\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T04:04:45Z","timestamp":1557461085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00941\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":124,"alternative-id":["10.3389\/fimmu.2019.00941"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00941","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,10]]},"article-number":"941"}}